BRIEF-Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test

Reuters10-03

Oct 3 (Reuters) - Lumos Diagnostics Holdings Ltd

* CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST

* CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY

* FUNDING TO SUPPORT COMING FEBRIDX® CLIA WAIVER STUDY AND US FDA APPLICATION

Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2472804816?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-10-03 09:04","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2472804816","market":null,"top_or_hot":-1,"title":"BRIEF-Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test","media":"Reuters","content":"<html><body><p>Oct 3 (Reuters) - Lumos Diagnostics Holdings Ltd</p><p> :</p><p>   * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST</p><p>   * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY</p><p>   * FUNDING TO SUPPORT COMING FEBRIDX® CLIA WAIVER STUDY AND US FDA APPLICATION</p><p>Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Lumos Diagnostics And Barda To Partner To Support FebriDx Bacterial/Non-Bacterial Point-Of-Care Test\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-10-03 09:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Oct 3 (Reuters) - Lumos Diagnostics Holdings Ltd :   * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST   * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM ...</p>\n\n<a href=\"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK7126","symbol_name":"医疗保健用品","start_time":0,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2472804816","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2472804816","pubTimestamp":1727917479,"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"Oct 3  - Lumos Diagnostics Holdings Ltd :   * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST   * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY   * FUNDING TO SUPPORT COMING FEBRIDX CLIA WAIVER STUDY AND US FDA APPLICATIONFurther company coverage:    ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK7126":"医疗保健用品","LDX.AU":"LUMOS DIAGNOSTICS HOLDINGS L"},"translate_title":"简介-Lumos Diagnostics和Barda合作支持FebriDx细菌/非细菌护理点测试","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LDX.AU":0.9},"content_text":"Oct 3 (Reuters) - Lumos Diagnostics Holdings Ltd :   * CO AND BARDA TO PARTNER TO SUPPORT FEBRIDX BACTERIAL/NON-BACTERIAL POINT-OF-CARE TEST   * CO AWARDED $3 MILLION IN NON-DILUTIVE FUNDING FROM BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY   * FUNDING TO SUPPORT COMING FEBRIDX® CLIA WAIVER STUDY AND US FDA APPLICATIONFurther company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2472804816"}